PELLUCID MARGINAL DEGENERATION

Clinical trials for PELLUCID MARGINAL DEGENERATION explained in plain language.

Never miss a new study

Get alerted when new PELLUCID MARGINAL DEGENERATION trials appear

Sign up with your email to follow new studies for PELLUCID MARGINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Light treatment aims to halt vision loss in down syndrome patients

Disease control Recruiting now

This study is testing an experimental treatment called corneal crosslinking (CXL) for people with Down syndrome who also have conditions that cause the clear front part of the eye (cornea) to thin and bulge, leading to worsening vision. The treatment involves applying vitamin B2 …

Matched conditions: PELLUCID MARGINAL DEGENERATION

Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

PELLUCID MARGINAL DEGENERATION

Get alerted when new PELLUCID MARGINAL DEGENERATION trials appear

Light treatment aims to halt vision loss in down syndrome patients